Related Experiment Video
Updated: Sep 20, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in
Hsin-Yuan Chen1, Yi-Fen Chiang2, Chun-Yung Huang3
1School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan; Department of Nutrition, I-Shou University, Kaohsiung 84001, Taiwan.
Abstract:
Metastasis is a major challenge in aggressive endometrial cancer treatment accounting for the high recurrence risk and poor prognosis of epithelial-mesenchymal transition (EMT), regulated by the transforming growth factor beta (TGFβ) signaling pathway, facilitates tumor metastasis. Spirulina phycocyanin extract (SPE) and its purified products allophycocyanin (APC) and C-phycocyanin (C-PC), derived from Spirulina platensis, can be considered a nutraceutical compound with the ability to inhibit tumor growth and metastasis. Current study aims to investigate the anti-metastatic potential of SPE, and its purified products APC, and C-PC on endometrial cancer both in vitro and in vivo. Firstly, human endometrial cancer cell lines (HEC-1A and Ishikawa) as an in vitro model. Secondly, HEC-1A cells transfected with luminescence gene were implanted into female nude mice as a xenograft model. MTT assay, transwell migration assay, immunoblotting assay, quantitative real-time polymerase chain reaction assay, and IVIS XRMS analysis techniques were used. The in vitro results showed that SPE and its purified products APC and C-PC inhibited cell migration, and altered the expression of EMT-related phenotypes by reversing the TGFβ/SMADs signaling pathway. The in vivo results indicated that SPE repressed the metastasis of HEC-1A-LUC cells through modulating EMT-related markers expression. Overall, SPE and its efficient components APC and C-PC reversed the EMT through targeting the TGFβ/SMADs signaling pathway, suggesting an effective therapeutic strategy for metastatic endometrial cancer.
Insights
Spirulina phycocyanin extract (SPE) and its components inhibit endometrial cancer metastasis by reversing epithelial-mesenchymal transition (EMT). These compounds target the TGFβ/SMADs pathway, offering a potential therapeutic strategy for aggressive endometrial cancer.
Area of Science:
- Oncology
- Natural Products Chemistry
- Molecular Biology
Background:
- Metastasis in endometrial cancer presents a significant clinical challenge, linked to high recurrence rates and poor prognosis.
- Epithelial-mesenchymal transition (EMT), driven by the transforming growth factor beta (TGFβ) pathway, is a key mechanism facilitating tumor metastasis.
- Spirulina phycocyanin extract (SPE) and its purified components, allophycocyanin (APC) and C-phycocyanin (C-PC), are natural compounds with potential anti-cancer properties.
Purpose of the Study:
- To investigate the anti-metastatic effects of SPE, APC, and C-PC on endometrial cancer.
- To elucidate the underlying molecular mechanisms, particularly the involvement of the TGFβ/SMADs signaling pathway and EMT markers.
Main Methods:
- In vitro studies utilized human endometrial cancer cell lines (HEC-1A, Ishikawa) with MTT and transwell migration assays.
- In vivo studies employed a HEC-1A xenograft mouse model, with IVIS XRMS analysis for metastasis tracking.
- Molecular analyses included immunoblotting and quantitative real-time polymerase chain reaction (qPCR) to assess EMT markers and signaling pathway components.
Main Results:
- SPE, APC, and C-PC significantly inhibited endometrial cancer cell migration in vitro.
- These compounds reversed EMT phenotypes by modulating the expression of EMT-related markers.
- The anti-metastatic effects were associated with the downregulation of the TGFβ/SMADs signaling pathway.
- In vivo, SPE demonstrated a significant repression of tumor metastasis in the xenograft model.
Conclusions:
- SPE and its purified components, APC and C-PC, exhibit potent anti-metastatic activity against endometrial cancer.
- The mechanism involves the reversal of EMT through targeted inhibition of the TGFβ/SMADs signaling pathway.
- These findings suggest that SPE and its components represent a promising nutraceutical therapeutic strategy for managing metastatic endometrial cancer.
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle

